Vaccine manufacturer Moderna said Wednesday the US Food and Drug Administration walked back its previous position and agreed to review the company’s new mRNA-based flu shot.
Continue Reading
News Source: medicalxpress.com
Vaccine manufacturer Moderna said Wednesday the US Food and Drug Administration walked back its previous position and agreed to review the company’s new mRNA-based flu shot.
News Source: medicalxpress.com
Leave a Reply